Synthesis method of quinazolinone derivative

Through the aromatic cycloelectrophilic dearomeric reaction of arylurea dearogenesis by oxidizing high-valent iodine reagents, dearomeric of non-activated aromatic hydrocarbons was successfully achieved, and quinazolinone derivatives were constructed, which solved the reaction conditions in the prior art. The harsh problem achieves efficient and gentle quinazolinone synthesis.

CN118994036AActive Publication Date: 2024-11-22CHANGZHOU UNIV
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411127585.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-22
Estimated Expiration
2044-08-16

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently realize the dearamization reaction of unactivated aromatic hydrocarbons, which usually require harsh reaction conditions, such as high temperature, high pressure, transition metal catalysis, etc., and the dearamization reaction of unactivated aromatic hydrocarbons regulated by high valence iodine has not yet been achieved.

Method used

The aromatic cycloelectrophilic dearomerization reaction of oxidized aryl urea derivatives using commercial inexpensive high-valent iodine reagents is used to generate quinazolinone derivatives by reacting with arylsulfonamide and high-valent iodine reagents in an organic solvent. The reaction conditions are 20-30°C, the reaction time is 12-24 hours, and the yield is as high as 76%.

Benefits of technology

1,4-functionalization of non-activated aromatic hydrocarbons is realized, and quinazolinone derivatives are efficiently constructed. The reaction conditions are mild and highly chemically selective, and paraselectively generated dearomerization products are produced. It has important pharmaceutical intermediates. Synthetic meaning.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention discloses a synthesis method of a quinazolinone derivative, and belongs to the technical field of organic chemistry. According to the method, aryl urea and aryl sulfonamide are used as reactants, a high-valence iodine reagent such as commercialized cheap iodobenzene diacetate is used as an oxidizing agent, hexafluoroisopropanol is used as a solvent, and the quinazolinone derivative can be obtained through reaction at the temperature of 20-30 DEG C. The method is simple to operate, the raw materials are easy to obtain, the reaction steps are short and efficient, and the reaction yield is as high as 76%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic chemistry, and particularly relates to a method for synthesizing a quinazolinone derivative. Background Art

[0002] Dearomatization reaction is widely used in modern organic synthesis as a classic strategy to convert planar molecules into 3D molecules. Compared with phenolic hydroxyl and heteroaromatic compounds (indole, pyridine, pyrrole and furan), benzene non-activated aromatics have higher resonance stabilization energy, and it is difficult to achieve their dearomatization transformation process. Therefore, how to efficiently achieve the dearomatization reaction of non-activated aromatics has always been a hot topic for organic chemists. At present, the dearomatization reaction of non-activated aromatics mainly depends on: 1) hydrogenation reduction reaction under high temperature and high pressure; 2) oxidation reaction of non-activated aromatics regulated by transition metals or light; 3) cycloaddition reaction of non-activated aromatics as dienes; 4) direct addition reaction of metal reagents (alkyl lithium reagents, etc.) to non-activated aromatics. These reactions to achieve dearomatization of non-activated aromatics usually require very harsh reaction conditions, such as high temperature, high pressure, transition metal catalysis, visible light regulation, etc. Therefore, developing efficient and mild dearomatization reactions of non-activated aromatics is a challenging research difficulty.

[0003]

[0004] Traditional non-activated aromatic dearomatization strategy In recent years, hypervalent iodine reagents have been widely used in the field of organic synthesis due to their low price, easy handling, low toxicity and environmental friendliness. At present, the dearomatization reaction of aromatic hydrocarbons using the hypervalent iodine oxidation strategy relies on the introduction of hydroxyl functional groups on the aromatic ring of aromatic compounds, thereby achieving the purpose of activating the substrate through a ligand exchange process. Therefore, the dearomatization reaction of phenolic hydroxyl compounds promoted by hypervalent iodine has developed rapidly, and a series of ortho- and para-substituted dearomatization target molecules have been constructed. Compared with this type of chemical transformation, the dearomatization reaction of non-activated aromatic hydrocarbons regulated by hypervalent iodine has not yet been achieved. In order to expand the application of hypervalent iodine reagents in dearomatization chemistry, we developed and designed diaryl urea reaction substrates to achieve the electrophilic dearomatization process of aromatic rings through hypervalent iodine oxidative coupling reactions.

[0005]

[0006] Design of a hypervalent iodine-promoted dearomatization reaction for non-activated aromatics Summary of the invention

[0007] The purpose of the present invention is to provide a method for synthesizing quinazolinone derivatives, by utilizing a commercially inexpensive high-valent iodine reagent to oxidize the aromatic ring electrophilic dearomatization reaction of an aryl urea derivative, thereby constructing a final quinazolinone derivative in high yield.

[0008] In order to achieve the above-mentioned object of the invention, the present invention adopts the following technical solutions: A method for synthesizing a quinazolinone derivative, wherein the reaction formula is as shown below:

[0009] Where R 1 , R 2 , R 3 , R 4 , R 5 Each is independently an electron withdrawing group or an electron donating group.

[0010] Furthermore, R 1 is halogen, methyl, isopropyl, tert-butyl, R 2 is methyl, ethyl, R 3 is methyl, ethyl, isopropyl, R 4 is hydrogen, halogen, methyl, ethyl, R 5 It is methyl and ethyl.

[0011] Specifically, the aryl urea derivative shown in formula a is used as a reactant, the aryl sulfonamide shown in formula b is used as a nucleophilic reagent, and a high-valent iodine reagent is used as an oxidant. The reaction is carried out in an organic solvent at 20-30° C. to obtain the quinazolinone derivative shown in formula c.

[0012] Furthermore, the aromatic urea derivatives are 1-(2',6'-dimethyl-1,1'-diphenyl)-3-methoxy-1-methylurea, 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, 1-(2',6'-dimethyl-1,1'-diphenyl)-3-isopropoxy-1-methylurea, 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-ethylurea, 3-ethoxy any one of 1-(2',4,6'-trimethyl-1,1'-diphenyl)urea, 1-(4-tert-butyl-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, 1-(4-chloro-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, and 3-ethoxy-1-(5-isopropyl-2',6'-dimethyl-1,1'-diphenyl)-1-methylurea.

[0013] Further, the aryl sulfonamide is 4-methylbenzenesulfonyl chloride, 4-ethylbenzenesulfonamide, 4-fluorobenzenesulfonamide, 3-methylbenzenesulfonamide, N ,4-dimethylbenzenesulfonamide, N -ethyl-4-methylbenzenesulfonamide.

[0014] Further, the hypervalent iodine reagent is one or more of iodobenzene acetate, iodosobenzene, and di(trifluoroacetic acid)iodobenzene. Preferably, the hypervalent iodine reagent is iodobenzene acetate.

[0015] Further, the organic solvent is one or more of hexafluoroisopropanol, trifluoroethanol, and acetonitrile. Preferably, the organic solvent is hexafluoroisopropanol.

[0016] Furthermore, the molar ratio of the reactants is: aryl urea: aryl sulfonamide: iodobenzene acetate = 2: 1: (2.0~4.0).

[0017] Furthermore, the molar concentration of the aryl urea in the organic solvent is 0.1-0.2 mol / L.

[0018] Furthermore, the reaction time is 12-24h.

[0019] Furthermore, the method also includes extracting the organic phase after the reaction is complete, and separating and purifying by column chromatography.

[0020] The method of the invention is simple to operate, the raw materials are easily available, the reaction steps are short and efficient, and the reaction yield is as high as 76%.

[0021] This method is not only efficient and mild, but also highly chemically selective. The reaction only produces para-substituted dearomatization products, successfully achieving the 1,4-functionalization of non-activated aromatics and constructing quinazolinone derivatives with two C–N bonds in one step. At the same time, the development of oxidation strategies for high-valent iodine reagents to efficiently synthesize such derivatives is of great significance to the development of pharmaceutical intermediates. DETAILED DESCRIPTION

[0022] The use of chemical synthesis methods to synthesize quinazolinone derivatives in pharmaceutical intermediates is of great significance, but it is difficult to achieve rapid and efficient synthesis using current chemical methods. After long-term research, the inventors found that aryl urea derivatives can be efficiently converted into quinazolinone using iodobenzene acetate as an oxidant.

[0023] The quinazolinone synthesis method of the present invention is shown in the following formula:

[0024] Where R 1 , R 2 , R 3 , R 4 , R 5 The group can be an electron withdrawing group or an electron donating group.

[0025] The molar ratio of the reactants is: aryl urea: aryl sulfonamide: iodobenzene acetate = 2: 1: (2.0~4.0).

[0026] Furthermore, the following methods may be selected: (1) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-methoxy-1-methylurea was placed in a reaction flask, 4-methylbenzenesulfonamide and iodobenzene acetate as an oxidant were added, and hexafluoroisopropanol was used as a solvent. The reaction was continued for 16 hours to obtain a high yield of the obtained product. N -(3'-methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide product; the molar ratio of the reactants is: 1-(2',6'-dimethyl-1,1'-diphenyl)-3-methoxy-1-methylurea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.0~3.0).

[0027] (2) Place 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea in a reaction bottle, add iodobenzene acetate and 4-methylbenzenesulfonamide as oxidants, and hexafluoroisopropanol as the reaction solvent, and react for 15 hours to obtain N -(3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide derivative; the molar ratio of the reactants is: 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.5~3.0).

[0028] (3) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-isopropoxy-1-methylurea, 4-methylbenzenesulfonamide and iodobenzene acetate as an oxidant were placed in a reaction bottle, hexafluoroisopropanol was added as a solvent, and the reaction was carried out for 20 hours to obtain a high yield of the product. N -(3'-isopropoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide product; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-isopropoxy-1-methylurea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1: (2.8~3.2).

[0029] (4) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-ethylurea was placed in a reaction bottle, iodobenzene acetate and 4-methylbenzenesulfonamide were added, and hexafluoroisopropanol was used as a solvent. The reaction was continued for 18 hours to obtain the product with high yield. N-(3'-ethoxy-1'-ethyl-2,6-dimethylquinazolinone)-4-methylbenzenesulfonamide derivative; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-ethylurea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.2~2.5).

[0030] (5) 3-ethoxy-1-methyl-1-(2',4,6'-trimethyl-1,1'-diphenyl)urea, iodobenzene acetate and 4-methylbenzenesulfonamide were placed in a reaction bottle, hexafluoroisopropanol was added as solvent, and the reaction was carried out for 12 hours to obtain the product with high yield. N -(3'-ethoxy-1',2,6,7'-tetramethylquinazolinone)-4-methylbenzenesulfonamide target product; 3-ethoxy-1-methyl-1-(2',4,6'-trimethyl-1,1'-diphenyl)urea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.5~3.0).

[0031] (6) 1-(4-tert-butyl-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, iodobenzene acetate as an oxidant and 4-methylbenzenesulfonamide were placed in a reaction bottle, hexafluoroisopropanol was added as a solvent, and the reaction was carried out for 22 hours to obtain a high yield of the obtained product. N -(7'-tert-butyl-3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide derivative; 1-(4-tert-butyl-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.6~3.0).

[0032] (7) 1-(4-chloro-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea was placed in a reaction bottle, iodobenzene acetate and 4-methylbenzenesulfonamide were added, and hexafluoroisopropanol was used as a solvent. The reaction was continued for 20 hours to obtain the product in high yield. N -(7'-chloro-3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide target product; 1-(4-chloro-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: 4-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.8~3.5).

[0033] (8) 3-ethoxy-1-(5-isopropyl-2',6'-dimethyl-1,1'-diphenyl)-1-methylurea, iodobenzene acetate as an oxidant and 4-methylbenzenesulfonamide were placed in a reaction bottle, hexafluoroisopropanol was added as a solvent, and the reaction was carried out for 24 hours to obtain a high yield of the product. N-(3'-ethoxy-6'-isopropyl-1',2,6-trimethylquinazolinone) - 4-Methylbenzenesulfonamide derivatives; N -Ethoxy-2,2-diphenylacetamide: iodobenzene: m-chloroperbenzoic acid = 2:1: (3.0~3.5).

[0034] (9) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea was placed in a reaction bottle, iodobenzene acetate and 4-ethylbenzenesulfonamide were added as oxidants, and hexafluoroisopropanol was used as solvent. The reaction was continued for 18 hours to obtain the product with high yield. N -(3'-ethoxy-1',2,6-trimethylquinazolinone)-4-ethylbenzenesulfonamide target product; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: 4-ethylbenzenesulfonamide: iodobenzene acetate = 2:1:(2.0~2.5).

[0035] (10) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, iodobenzene acetate as an oxidant, and 4-fluorobenzenesulfonamide were placed in a reaction bottle, and hexafluoroisopropanol was added as a solvent. The reaction was continued for 22 hours to obtain a high yield of the obtained product. N -(3'-ethoxy-6'-isopropyl-1',2,6-trimethylquinazolinone) - 4-Fluorobenzenesulfonamide derivative; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: 4-fluorobenzenesulfonamide: iodobenzene acetate = 2:1: (3.5~4.0).

[0036] (11) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea was placed in a reaction flask, iodobenzene acetate and 3-methylbenzenesulfonamide were added as oxidants, and hexafluoroisopropanol was used as solvent. The reaction was continued for 20 hours to obtain the product with high yield. N -(3'-ethoxy-1',2,6-trimethylquinazolinone)-3-methylbenzenesulfonamide target product; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: 3-methylbenzenesulfonamide: iodobenzene acetate = 2:1:(3.0~3.5).

[0037] (12) 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, iodobenzene acetate as an oxidant and 4-fluorobenzenesulfonamide N ,4-Dimethylbenzenesulfonamide was placed in a reaction bottle, hexafluoroisopropanol was added as solvent, and the reaction was continued for 24 hours to obtain high yield N-(3'-ethoxy-1',2,6-trimethylquinazolinone) -N ,4-dimethylbenzenesulfonamide derivatives; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: N ,4-Dimethylbenzenesulfonamide:iodobenzene acetate = 2:1:(3.2~3.6).

[0038] (13) Place 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea in a reaction flask, add iodobenzene acetate as an oxidant and N -ethyl-4-methylbenzenesulfonamide, hexafluoroisopropanol as solvent, react for 24 hours to obtain high yield N -(3'-ethoxy-1',2,6-trimethylquinazolinone)- N -ethyl-4-methylbenzenesulfonamide target product; 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea: N -Ethyl-4-methylbenzenesulfonamide: iodobenzene acetate = 2:1: (3.6~4.0).

[0039] In the above reaction, the reaction temperature ranges from 20 to 30°C.

[0040] In the above reaction, the synthesis method of aryl urea derivatives is referenced by: Y. Wang, Y.-Y. Sun, Y.-M.Cui, Y.-X. Yu, Z.-G. Wu, J. Org. Chem. 2022, 87 , 3234. Example 1

[0041] N Synthesis of -(3'-methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide

[0042] Add 1-(2',6'-dimethyl-1,1'-diphenyl)-3-methoxy-1-methylurea (56.8 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (64.4 mg, 0.2 mmol) to a 10 mL reaction tube, and finally add 1 mL of hexafluoroisopropanol (HFIP) to dissolve it and stir at room temperature overnight. After the reaction is complete, add 5 mL of saturated NaHCO3 solution, extract with dichloromethane three times, combine the organic phases, dry with anhydrous Na2SO4, spin dry, and finally separate and purify by column chromatography to obtain the product as a light yellow solid. N-(3'-Methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide (25.4 mg, yield 56%).

[0043] mp 242–243 o C; 1 H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H),7.33 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 6.9 Hz, 1H), 6.92 (t, J = 7.5 Hz, 1H),6.82 (d, J = 8.2 Hz, 1H), 6.76 (d, J = 9.4 Hz, 1H), 5.57 (s, 2H), 4.57 (d, J = 9.8 Hz, 1H), 4.40 – 4.33 (m, 1H), 3.77 (s, 3H), 3.36 (s, 3H), 2.44 (s, 3H), 1.53 (s, 6H); 13 C NMR (100 MHz, CDCl3) δ 154.7, 143.7, 138.4, 138.0, 137.5,129.9, 129.2, 127.2, 126.8, 125.1, 123.0, 122.7, 113.2, 68.8, 63.6, 47.9,30.1, 21.7, 18.9; ESI FTMS exact mass calcd for (C 24 H 27 N3O4S+Na) + requires m / z476.1620, found m / z 476.1611. Example 2

[0044] N Synthesis of -(3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide

[0045] 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (59.6 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (96.6 mg, 0.3 mmol) were added to a 10 mL reaction tube, and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and dichloromethane was extracted three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun to dryness. Finally, the product was separated and purified by column chromatography to obtain a yellow solid. N -(3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide (35.5 mg, yield 76%).

[0046] mp 172–173 o C; 1 H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 7.9 Hz, 2H),7.30 (d, J = 7.9 Hz, 2H), 7.19 (t, J = 7.9 Hz, 1H), 6.87 (t, J = 7.6 Hz, 1H),6.79 (d, J = 8.3 Hz, 1H), 6.73 (d, J = 7.7 Hz, 1H), 5.54 (s, 2H), 4.65 (d, J = 9.4 Hz, 1H), 4.33 (s, 1H), 4.00 – 3.92 (m, 2H), 3.31 (s, 3H), 2.40 (s, 3H), 1.49 (s, 6H), 1.22 – 1.11 (m, 3H); 13 C NMR (100 MHz, CDCl3) δ 154.6, 143.5,138.2, 137.8, 137.5, 129.8, 129.0, 127.0, 126.7, 124.8, 122.8, 122.4, 113.0,71.3, 68.7, 47.7, 29.9, 21.5, 18.7, 13.8; ESI FTMS exact mass calcd for(C 25 H 29 N3O4S+Na) +requires m / z 490.1777, found m / z 490.1770. Example 3

[0047] N Synthesis of -(3'-isopropoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide

[0048] Add 1-(2',6'-dimethyl-1,1'-diphenyl)-3-isopropoxy-1-methylurea (62.4 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (90.2 mg, 0.28 mmol) to a 10 mL reaction tube, and finally add 1 mL of hexafluoroisopropanol (HFIP) to dissolve it and stir at room temperature overnight. After the reaction is complete, add 5 mL of saturated NaHCO3 solution, extract with dichloromethane 3 times, combine the organic phases, dry with anhydrous Na2SO4, spin dry, and finally separate and purify by column chromatography to obtain the product as a yellow solid. N -(3'-Isopropoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide (19.7 mg, yield 41%).

[0049] mp 180–181 o C; 1 H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 2H),7.33 (d, J = 8.0 Hz, 2H), 7.25 – 7.18 (m, 1H), 6.90 (t, J = 7.5 Hz, 1H), 6.81(d, J = 8.2 Hz, 1H), 6.75 (d, J = 7.7 Hz, 1H), 5.56 (s, 2H), 4.44 – 4.30 (m,2H), 4.15 – 4.04 (m, 1H), 3.35 (s, 3H), 2.44 (s, 3H), 1.52 (s, 6H), 1.23 (d, J = 6.2 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 156.3, 143.7, 138.2, 138.2, 138.1,130.0, 129.1, 127.2, 127.1, 124.8, 123.0, 122.5, 113.2, 69.6, 48.0, 30.5,21.7, 21.6, 19.1; ESI FTMS exact mass calcd for (C 26 H 31 N3O4S+Na) + requires m / z504.1933, found m / z 504.1931. Example 4

[0050] N Synthesis of -(3'-ethoxy-1'-ethyl-2,6-dimethylquinazolinone)-4-methylbenzenesulfonamide

[0051] 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-ethylurea (62.4 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (74.1 mg, 0.23 mmol) were added to a 10 mL reaction tube, and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and the product was extracted with dichloromethane three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun to dryness. Finally, the product was separated and purified by column chromatography to obtain a yellow solid. N -(3'-ethoxy-1'-ethyl-2,6-dimethylquinazolinone)-4-methylbenzenesulfonamide (24.1 mg, yield 50%).

[0052] mp 188–189 o C; 1 H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 2H),7.33 (d, J = 8.0 Hz, 2H), 7.22 (t, J = 7.8 Hz, 1H), 6.91 – 6.83 (m, 2H), 6.76(d, J = 7.8 Hz, 1H), 5.57 (s, 2H), 4.46 (d, J= 9.7 Hz, 1H), 4.37 – 4.30 (m,1H), 4.01 – 3.94 (m, 4H), 2.44 (s, 3H), 1.52 (s, 6H), 1.24 – 1.19 (m, 6H); 13 CNMR (100 MHz, CDCl3) δ 154.5, 143.7, 138.3, 137.8, 136.7, 130.0, 129.1,129.0, 127.3, 127.2, 125.1, 123.3, 122.5, 113.2, 71.6, 68.7, 47.9, 37.6,21.7, 18.9, 13.9, 12.4; ESI FTMS exact mass calcd for (C 26 H 31 N3O4S+Na) + requires m / z 504.1933, found m / z 504.1922. Example 5

[0053] N Synthesis of -(3'-ethoxy-1',2,6,7'-tetramethylquinazolinone)-4-methylbenzenesulfonamide

[0054] Add 3-ethoxy-1-methyl-1-(2',4,6'-trimethyl-1,1'-diphenyl)urea (62.4 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (96.6 mg, 0.3mmol) to a 10 mL reaction tube, and finally add 1 mL of hexafluoroisopropanol (HFIP) to dissolve it and stir at room temperature overnight. After the reaction is complete, add 5 mL of saturated NaHCO3 solution, extract with dichloromethane 3 times, combine the organic phases, dry with anhydrous Na2SO4, spin dry, and finally separate and purify by column chromatography to obtain the product as a light yellow solid. N -(3'-ethoxy-1',2,6,7'-tetramethylquinazolinone)-4-methylbenzenesulfonamide (24.1 mg, yield 50%).

[0055] mp 207–208 o C; 1 H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.1 Hz, 2H),7.33 (d, J= 8.0 Hz, 2H), 6.72 (d, J = 7.9 Hz, 1H), 6.65 – 6.59 (m, 2H), 5.56(s, 2H), 4.43 (d, J = 9.6 Hz, 1H), 4.37 – 4.28 (m, 1H), 3.98 (q, J = 7.1 Hz,2H), 3.34 (s, 3H), 2.43 (s, 3H), 2.31 (s, 3H), 1.51 (s, 6H), 1.21 (t, J = 7.1Hz, 3H); 13 C NMR (100 MHz, CDCl3) δ 154.9, 143.7, 139.1, 138.4, 137.9, 129.9,127.2, 126.8, 124.9, 123.4, 120.1, 113.8, 71.5, 68.6, 47.9, 30.0, 21.7, 21.6,18.9, 13.9; ESI FTMS exact mass calcd for (C 26 H 31 N3O4S+Na) + requires m / z504.1933, found m / z 504.1923. Example 6

[0056] N Synthesis of -(7'-tert-butyl-3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide

[0057] 1-(4-tert-butyl-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (70.8 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (96.6 mg, 0.3 mmol) were added to a 10 mL reaction tube, and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and the product was extracted with dichloromethane three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun to dryness. Finally, the product was separated and purified by column chromatography to obtain a light yellow solid. N-(7'-tert-Butyl-3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide (19.9 mg, yield 38%).

[0058] mp 207–208 o C; 1 H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 2H),7.33 (d, J = 8.0 Hz, 2H), 6.92 (d, J = 8.3 Hz, 1H), 6.79 (s, 1H), 6.66 (d, J = 8.2 Hz, 1H), 5.56 (s, 2H), 4.44 – 4.30 (m, 2H), 4.04 – 3.94 (m, 2H), 3.37(s, 3H), 2.44 (s, 3H), 1.52 (s, 6H), 1.28 (s, 9H), 1.22 (t, J = 7.0 Hz, 3H); 13 C NMR (100 MHz, CDCl3) δ 155.1, 152.5, 143.7, 138.4, 138.0, 137.6, 129.9,127.2, 126.5, 124.9, 120.1, 119.8, 110.2, 71.5, 68.6, 48.0, 34.9, 31.4, 30.0,21.7, 19.0, 14.0; ESI FTMS exact mass calcd for (C 29 H 37 N3O4S+Na) + requires m / z546.2403, found m / z 546.2395. Example 7

[0059] N Synthesis of -(7'-chloro-3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide

[0060] Add 1-(4-chloro-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (66.4 mg, 0.2 mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (106.3 mg, 0.33 mmol) to a 10 mL reaction tube, and finally add 1 mL of hexafluoroisopropanol (HFIP) to dissolve it and stir at room temperature overnight. After the reaction is complete, add 5 mL of saturated NaHCO3 solution, extract with dichloromethane 3 times, combine the organic phases, dry with anhydrous Na2SO4, spin dry, and finally separate and purify by column chromatography to obtain the product as a light yellow solid. N -(7'-Chloro-3'-ethoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide (21.0 mg, yield 42%).

[0061] mp 186–187 o C; 1 H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 2H),7.34 (d, J = 8.0 Hz, 2H), 6.89 (d, J = 8.4 Hz, 1H), 6.81 (s, 1H), 6.68 (d, J = 8.3 Hz, 1H), 5.59 (s, 2H), 4.42 – 4.30 (m, 2H), 4.04 – 3.94 (m, 2H), 3.33(s, 3H), 2.44 (s, 3H), 1.52 (s, 6H), 1.22 (t, J = 7.1 Hz, 3H); 13 C NMR (100MHz, CDCl3) δ 154.3, 143.8, 139.3, 138.3, 137.3, 134.8, 130.0, 128.2, 127.2,122.5, 121.5, 113.4, 71.6, 68.6, 47.8, 30.2, 21.7, 18.8, 13.9; ESI FTMS exactmass calcd for (C 25 H 28 ClN3O4S+Na) + requires m / z 524.1387, found m / z 524.1378. Example 8

[0062] N -(3'-ethoxy-6'-isopropyl-1',2,6-trimethylquinazolinone) - Synthesis of 4-Methylbenzenesulfonamide

[0063] 3-Ethoxy-1-(5-isopropyl-2',6'-dimethyl-1,1'-diphenyl)-1-methylurea (68.0 mg, 0.2mmol), 4-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (103.0 mg, 0.32 mmol) were added to a 10mL reaction tube, and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and the product was extracted with dichloromethane three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun to dryness. Finally, the product was separated and purified by column chromatography to obtain a light yellow solid. N -(3'-ethoxy-6'-isopropyl-1',2,6-trimethylquinazolinone) - 4-Methylbenzenesulfonamide (26.0 mg, 51% yield).

[0064] mp 155–156 o C; 1 H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.8 Hz, 2H),7.33 (d, J = 7.9 Hz, 2H), 7.09 (d, J = 8.4 Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H),6.57 (s, 1H), 5.59 (s, 2H), 4.45 – 4.33 (m, 2H), 4.03 – 3.93 (m, 2H), 3.33(s, 3H), 2.81 – 2.70 (m, 1H), 2.44 (s, 3H), 1.51 (s, 6H), 1.23 (t, J = 7.2Hz, 3H), 1.14 (d, J = 6.9 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 154.9, 143.7,143.4, 138.5, 137.8, 136.0, 129.9, 127.2, 126.7, 125.0, 122.7, 113.2, 71.6,68.8, 47.9, 33.3, 30.1, 24.1, 21.7, 18.9, 13.9; ESI FTMS exact mass calcd for(C 28 H 35 N3O4S+Na) + requires m / z 532.2246, found m / z 532.2239. Example 9

[0065] N Synthesis of -(3'-ethoxy-1',2,6-trimethylquinazolinone)-4-ethylbenzenesulfonamide

[0066] Add 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (59.6 mg, 0.2 mmol), 4-ethylbenzenesulfonamide (18.5 mg, 0.1 mmol), iodobenzene acetate (80.5 mg, 0.25mmol) to a 10 mL reaction tube, and finally add 1 mL of hexafluoroisopropanol (HFIP) to dissolve it and stir at room temperature overnight. After the reaction is complete, add 5 mL of saturated NaHCO3 solution, extract with dichloromethane 3 times, combine the organic phases, dry with anhydrous Na2SO4, spin dry, and finally separate and purify by column chromatography to obtain the product as a light yellow solid. N -(3'-Ethoxy-1',2,6-trimethylquinazolinone)-4-ethylbenzenesulfonamide (16.4 mg, 34% yield).

[0067] mp 147–148 o C; 1 H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 8.1 Hz, 2H),7.35 (d, J = 7.9 Hz, 2H), 7.22 (d, J = 8.6 Hz, 1H), 6.91 (t, J = 7.6 Hz, 1H),6.82 (d, J = 8.3 Hz, 1H), 6.76 (d,J = 7.7 Hz, 1H), 5.57 (s, 2H), 4.43 (d, J = 9.7 Hz, 1H), 4.39 – 4.32 (m, 1H), 4.04 – 3.95 (m, 2H), 3.35 (s, 3H), 2.76 –2.69 (m, 2H), 1.52 (s, 6H), 1.28 – 1.21 (m, 6H); 13 C NMR (100 MHz, CDCl3) δ154.8, 149.9, 138.5, 138.0, 137.7, 129.1, 128.8, 127.3, 126.9, 125.1, 123.0,122.6, 113.2, 71.6, 68.8, 47.9, 30.1, 29.0, 18.9, 15.4, 14.0; ESI FTMS exactmass calcd for (C 26 H 31 N3O4S+Na) + requires m / z 504.1933, found m / z 504.1927. Example 10

[0068] N -(3'-ethoxy-6'-isopropyl-1',2,6-trimethylquinazolinone) - Synthesis of 4-Fluorobenzenesulfonamide

[0069] 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (59.6 mg, 0.2 mmol), 4-fluorobenzenesulfonamide (17.5 mg, 0.1 mmol), iodobenzene acetate (128.8 mg, 0.40 mmol) were added to a 10 mL reaction tube, and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and the product was extracted with dichloromethane three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun to dryness. Finally, the product was separated and purified by column chromatography to obtain a yellow solid. N -(3'-ethoxy-6'-isopropyl-1',2,6-trimethylquinazolinone) - 4-Fluorobenzenesulfonamide (12.7 mg, 27% yield).

[0070] mp 218–220 o C;1 H NMR (400 MHz, CDCl3) δ 7.99 – 7.92 (m, 2H), 7.22(t, J = 8.4 Hz, 3H), 6.92 (t, J = 7.6 Hz, 1H), 6.83 (d, J = 8.3 Hz, 1H), 6.76(d, J = 7.8 Hz, 1H), 5.59 (s, 2H), 4.49 (d, J = 9.7 Hz, 1H), 4.37 (s, 1H), 4.04 – 3.96 (m, 2H), 3.36 (s, 3H), 1.54 (s, 6H), 1.23 (t, J = 7.1 Hz, 3H); 13 CNMR (100MHz, CDCl3) δ 154.8, 138.1, 137.5, 129.9 (d, J = 9.2 Hz), 129.2,126.9, 124.9, 122.8 (d, J = 23.6 Hz), 116.6 (d, J = 22.5 Hz), 113.2, 71.6,68.8, 48.0, 30.1, 18.9, 14.1; 19 F NMR (282 MHz, CDCl3) δ -105.1; ESI FTMSexact mass calcd for (C 24 H 26 FN3O4S+Na) + requires m / z 494.1526, found m / z494.1519. Embodiment 11

[0071] N Synthesis of -(3'-ethoxy-1',2,6-trimethylquinazolinone)-3-methylbenzenesulfonamide

[0072] Add 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (59.6 mg, 0.2 mmol), 3-methylbenzenesulfonamide (17.1 mg, 0.1 mmol), iodobenzene acetate (112.7 mg, 0.35mmol) to a 10 mL reaction tube, and finally add 1 mL of hexafluoroisopropanol (HFIP) to dissolve it and stir at room temperature overnight. After the reaction is complete, add 5 mL of saturated NaHCO3 solution, extract with dichloromethane 3 times, combine the organic phases, dry with anhydrous Na2SO4, spin dry, and finally separate and purify by column chromatography to obtain the product as a light yellow solid. N -(3'-ethoxy-1',2,6-trimethylquinazolinone)-3-methylbenzenesulfonamide (10.7 mg, yield 23%).

[0073] mp 185–186 o C; 1 H NMR (400 MHz, CDCl3) δ 7.78 – 7.68 (m, 2H), 7.42 –7.37 (m, 2H), 7.22 (d, J = 7.3 Hz, 1H), 6.92 (t, J = 7.6 Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H), 6.77 (d, J = 7.7 Hz, 1H), 5.58 (s, 2H), 4.46 – 4.33 (m, 2H), 4.05 – 3.95 (m, 2H), 3.35 (s, 3H), 2.45 (s, 3H), 1.23 (t, J = 7.2 Hz, 3H); 13 CNMR (100 MHz, CDCl3) δ 154.8, 141.2, 139.6, 138.1, 137.8, 133.7, 129.2,129.1, 127.5, 127.0, 124.2, 122.6, 113.2, 71.6, 68.8, 48.0, 30.1, 21.5, 18.9,14.0; ESI FTMS exact mass calcd for (C 25 H 29 N3O4S+Na) + requires m / z 490.1777,found m / z 490.1771. Example 12

[0074] N -(3'-ethoxy-1',2,6-trimethylquinazolinone) -N ,Synthesis of 4-Dimethylbenzenesulfonamide

[0075] 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (59.6 mg, 0.2 mmol), 4-fluorobenzenesulfonamide N ,4-Dimethylbenzenesulfonamide (18.5 mg, 0.1 mmol), iodobenzene acetate (112.7 mg, 0.35 mmol) were added to a 10 mL reaction tube, and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and dichloromethane was extracted three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun dry. Finally, the product was separated and purified by column chromatography to obtain a yellow solid. N -(3'-ethoxy-1',2,6-trimethylquinazolinone) -N ,4-Dimethylbenzenesulfonamide (30.3 mg, yield 63%).

[0076] mp 218–219 o C; 1 H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.8 Hz, 2H),7.33 (d, J = 7.9 Hz, 2H), 7.23 (d, J = 7.9 Hz, 1H), 6.93 (t, J = 7.6 Hz, 1H),6.82 (d, J = 9.5 Hz, 2H), 5.38 (s, 2H), 5.04 (s, 1H), 4.04 – 3.97 (m, 2H), 3.35 (s, 3H), 2.70 (s, 3H), 2.44 (s, 3H), 1.57 (s, 6H), 1.12 (t, J = 7.2 Hz,3H); 13C NMR (100 MHz, CDCl3) δ 154.9, 143.5, 139.7, 138.0, 137.1, 129.9,129.1, 127.3, 126.9, 123.8, 123.2, 122.6, 113.1, 71.2, 69.1, 52.2, 30.1,29.7, 21.7, 18.9, 13.7; ESI FTMS exact mass calcd for (C 26 H 31 N3O4S+Na) + requires m / z 504.1933, found m / z 504.1930. Example 13

[0077] N -(3'-ethoxy-1',2,6-trimethylquinazolinone)- N -Synthesis of ethyl-4-methylbenzenesulfonamide

[0078] Add 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea (59.6 mg, 0.2 mmol) to a 10 mL reaction tube. N -ethyl-4-methylbenzenesulfonamide (19.9 mg, 0.1 mmol), iodobenzene acetate (122.4 mg, 0.38 mmol), and finally 1 mL of hexafluoroisopropanol (HFIP) was added to dissolve it and stirred at room temperature overnight. After the reaction was complete, 5 mL of saturated NaHCO3 solution was added, and dichloromethane was extracted three times. The organic phases were combined, dried over anhydrous Na2SO4, and then spun dry. Finally, the product was separated and purified by column chromatography to obtain a light yellow solid. N -(3'-ethoxy-1',2,6-trimethylquinazolinone)- N -ethyl-4-methylbenzenesulfonamide (15.3 mg, yield 31%). Embodiment 14

[0079] Substituting iodobenzene for iodobenzene acetate in Example 1, the product N -(3'-methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide 13.1 mg, yield 29%. Embodiment 15

[0080] Substituting di(trifluoroacetic acid) iodobenzene for the iodobenzene acetate in Example 1, the product N-(3'-methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide 3.6 mg, yield 8%. Example 16

[0081] Substituting trifluoroethanol for the hexafluoroisopropanol in Example 1, the product N -(3'-methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide 4.5 mg, yield 10%. Embodiment 17

[0082] The product was obtained by replacing the hexafluoroisopropanol in Example 1 with acetonitrile. N -(3'-methoxy-1',2,6-trimethylquinazolinone)-4-methylbenzenesulfonamide 5.9 mg, yield 13%.

[0083] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any technician familiar with the profession, without departing from the scope of the technical solution of the present invention, according to the technical essence of the present invention, any simple modification, equivalent replacement and improvement made to the above embodiment still falls within the protection scope of the technical solution of the present invention.

Claims

1. A method for synthesizing a quinazolinone derivative, characterized in that: In the presence of a high-valent iodine reagent and an organic solvent, the aryl urea shown in formula a reacts with the aryl sulfonamide shown in formula b to obtain a quinazolinone derivative shown in formula c; the reaction formula is as follows: , where R 1 is methyl, isopropyl, tert-butyl, halogen, R 2 Ethyl, R 3 is methyl, ethyl or isopropyl, R 4 is methyl, ethyl, halogen, R 5 It is methyl and ethyl.

2. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The reaction is carried out at 20-30° C. for 12-24 hours.

3. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The high-valent iodine reagent is one or more of iodobenzene acetate, iodosobenzene, and di(trifluoroacetic acid)iodobenzene.

4. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The organic solvent is one or more of hexafluoroisopropanol, trifluoroethanol and acetonitrile.

5. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The aromatic urea is 1-(2',6'-dimethyl-1,1'-diphenyl)-3-methoxy-1-methyl urea, 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methyl urea, 1-(2',6'-dimethyl-1,1'-diphenyl)-3-isopropoxy-1-methyl urea, 1-(2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-ethyl urea, 3-ethoxy-1- Any one of methyl-1-(2',4,6'-trimethyl-1,1'-diphenyl)urea, 1-(4-tert-butyl-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, 1-(4-chloro-2',6'-dimethyl-1,1'-diphenyl)-3-ethoxy-1-methylurea, and 3-ethoxy-1-(5-isopropyl-2',6'-dimethyl-1,1'-diphenyl)-1-methylurea.

6. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The aryl sulfonamide is 4-methylbenzenesulfonyl chloride, 4-ethylbenzenesulfonamide, 4-fluorobenzenesulfonamide, 3-methylbenzenesulfonamide, N ,4-dimethylbenzenesulfonamide, N -ethyl-4-methylbenzenesulfonamide.

7. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The molar ratio of the aryl urea, aryl sulfonamide and high-valent iodine reagent is 2:1:2-4.

8. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The molar concentration of the aryl urea in the organic solvent is 0.1-0.2 mol / L.

9. The method for synthesizing a quinazolinone derivative according to claim 1, characterized in that: The method also includes extracting the organic phase and performing column chromatography separation and purification after the reaction is complete.

Citation Information

Patent Citations

  • Preparation method of multi-substituted quinazoline derivative

    CN103204818A

  • Preparation method of N-acetyl dimethylamino indole-2-ketone derivative

    CN107540597A

  • Synthesis method of benzo hydrogenated imidazolone skeleton

    CN113651758A

  • Preparation method of quinazolinone derivative

    CN115850193A